Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Genesis raises $30 million in financing
The notes carry an annual interest rate of 6% and are convertible into shares of the company’s common stock at a conversion price of $0.20 per share. In
The notes carry an annual interest rate of 6% and are convertible into shares of the company’s common stock at a conversion price of $0.20 per share. In
The new high-density 2.1 million probe (HD2) arrays of Roche NimbleGen combined with proprietary software, Nexus Copy Number, of BioDiscovery bring unprecedented power and ease in whole-genome comparative
To offer integrated workflows to glycomics researchers, Applied Biosystems and MDS Analytical Technologies will co-market and resell Premier Biosoft’s SimGlycan, a high throughput glycan mass finger-printing tool, for
Addrenex is also continuing to enroll patients in an additional Phase III trial using Clonicel in combination with stimulants such as methylphenidate and dextro-amphetamine/amphetamine to treat attention deficit
The company will also be awarded a patent term adjustment of an additional 470 days, providing Eurand with coverage on Amrix until at least February 26, 2025. Eurand’s
Under this multi-year exclusive agreement for optical coherence tomography (OCT) dental imaging, Axsun will supply the integrated OCT engine for Lantis’s OCT Dental Imaging System, to be introduced
Innogenetics shareholders will receive E6.10 per share in cash, or approximately E188 million. The combined entity is expected to be the largest standalone molecular diagnostics company in the
The compound was found to have significant activity against hepatitis C virus (HCV) under assay conditions designed to demonstrate inhibition of the virus entry process, using a newly
In the recent animal study, the therapeutic efficacy of Zysolin was investigated in a mouse model of Pseudomonas aeruginosa pneumonia. In this acute model, pneumonia developed rapidly, resulting
Results demonstrated that a single five microgram dose of the company’s H5N1 VLP vaccine induced high levels of antibodies in 100% of ferrets and met all required immunogenicity